NASDAQ
Arch Therapeutics, Inc. (ARTH) has a fcf yield of -84.55% as of Friday, May 29, 2026. This represents a 187.26% decrease compared to its 12-month average of -29.43%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.